Microbubble-Assisted p53, RB, and p130 Gene Transfer in Combination with Radiation Therapy in Prostate Cancer

被引:11
|
作者
Nande, Rounak [1 ]
Greco, Adelaide [1 ,2 ]
Gossman, Michael S. [3 ]
Lopez, Jeffrey P. [3 ]
Claudio, Luigi [4 ]
Salvatore, Marco [2 ]
Brunetti, Arturo [2 ]
Denvir, James [1 ]
Howard, Candace M. [1 ]
Claudio, Pier Paolo [1 ,5 ]
机构
[1] Marshall Univ, Joan C Edwards Sch Med, Translat Genom Res Inst, Dept Biochem & Microbiol, Huntington, WV 25755 USA
[2] Univ Naples Federico II, Dept Biomorphol & Funct Sci, Naples, Italy
[3] Tri State Reg Canc Ctr, Dept Radiat Oncol, Ashland, KY USA
[4] Fdn Senatore Pascale, Natl Canc Inst, Dept Urol, Naples, Italy
[5] Marshall Univ, Dept Surg, Huntington, WV 25755 USA
关键词
Retinoblastoma; RB; p130; p53; tumor suppressor gene; microbubbles; ultrasound; systemic targeted viral gene delivery; radiation; external beam radiation; apoptosis induction; prostate cancer; WILD-TYPE P53; CELL-CYCLE; INTRATUMORAL INJECTION; IN-VITRO; APOPTOSIS; RADIOTHERAPY; EXPRESSION; EFFICACY; PROTEIN; ADENOVIRUS;
D O I
10.2174/1566523211313030001
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Combining radiation therapy and direct intratumoral (IT) injection of adenoviral vectors has been explored as a means to enhance the therapeutic potential of gene transfer. A major challenge for gene transfer is systemic delivery of nucleic acids directly into an affected tissue. Ultrasound (US) contrast agents (microbubbles) are viable candidates to enhance targeted delivery of systemically administered genes. Here we show that p53, pRB, and p130 gene transfer mediated by US cavitation of microbubbles at the tumor site resulted in targeted gene transduction and increased reduction in tumor growth compared to DU-145 prostate cancer cell xenografts treated intratumorally with adenovirus (Ad) or radiation alone. Microbubble-assisted/US-mediated Ad.p53 and Ad.RB treated tumors showed significant reduction in tumor volume compared to Ad.p130 treated tumors (p < 0.05). Additionally, US mediated microbubble delivery of p53 and RB combined with external beam radiation resulted in the most profound tumor reduction in DU-145 xenografted nude mice (p < 0.05) compared to radiation alone. These findings highlight the potential therapeutic applications of this novel image-guided gene transfer technology in combination with external beam radiation for prostate cancer patients with therapy resistant disease.
引用
收藏
页码:163 / 174
页数:12
相关论文
共 50 条
  • [31] A mouse model of pRb2/p130 in prostate cancer
    Boffo, Silvia
    Klein-Szanto, Andres J.
    Rizzolio, Flavio
    Giordano, Antonio
    CANCER RESEARCH, 2015, 75
  • [32] RB, p130 and p107 differentially repress G1/S and G2/M genes after p53 activation
    Schade, Amy E.
    Fischer, Martin
    DeCaprio, James A.
    NUCLEIC ACIDS RESEARCH, 2019, 47 (21) : 11197 - 11208
  • [33] The role of p53 in radiation therapy outcomes for favorable-to-intermediate-risk prostate cancer
    Ritter, MA
    Gilchrist, KW
    Voytovich, M
    Chappell, RJ
    Verhoven, BM
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 53 (03): : 574 - 580
  • [34] p53 and bcl-2 immunohistochemical alterations in prostate cancer treated with radiation therapy
    Huang, A
    Gandour-Edwards, R
    Rosenthal, SA
    Siders, DB
    Deitch, AD
    deVere White, RW
    UROLOGY, 1998, 51 (02) : 346 - 351
  • [35] p107, but Not p130, Cooperates with the Retinoblastoma Protein (Rb) To Suppress Lung Cancer.
    Simpson, D. S.
    Gettler, C. A.
    Wikenheiser-Brokamp, K. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [36] Adenovirus p53 gene therapy
    Roth, JA
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (01) : 55 - 61
  • [37] Assessment of p53 gene transfer and biological activities in a clinical study of adenovirus-p53 gene therapy for recurrent ovarian cancer
    Wen, SF
    Mahavni, V
    Quijano, E
    Shinoda, J
    Grace, M
    Musco-Hobkinson, ML
    Yang, TY
    Chen, YT
    Runnenbaum, I
    Horowitz, J
    Maneval, D
    Hutchins, B
    Buller, R
    CANCER GENE THERAPY, 2003, 10 (03) : 224 - 238
  • [38] Assessment of p53 gene transfer and biological activities in a clinical study of adenovirus-p53 gene therapy for recurrent ovarian cancer
    Shu Fen Wen
    Vikas Mahavni
    Erlinda Quijano
    Jeremy Shinoda
    Michael Grace
    Mary Lynn Musco-Hobkinson
    Tong-Yuan Yang
    Yuetian Chen
    Ingo Runnenbaum
    JoAnn Horowitz
    Dan Maneval
    Beth Hutchins
    Richard Buller
    Cancer Gene Therapy, 2003, 10 : 224 - 238
  • [39] Cancer gene therapy with mitochondria-targeting p53 gene
    Umemoto, Takuya
    Hirashima, Koji
    Asai, Tomohiro
    Mihara, Motohiro
    Miyagawa, Shin-ichi
    Oku, Naoto
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2008, 128 : 101 - 102
  • [40] Recombinant adenovirus p53 transfer in combination with hyperthermia in advanced cancer
    Zhang, Shanwen
    HUMAN GENE THERAPY, 2007, 18 (10) : 996 - 996